PT  - JOURNAL ARTICLE
AU  - Cunningham, Muriel
ED  - Morrow, David A.
TI  - Ranolazine Reduces Recurrent Ischemia in Patients with Non-ST Elevation ACS
DP  - 2007 Jun 01
TA  - MD Conference Express
PG  - 20--21
VI  - 7
IP  - 1
4099  - http://mdc.sagepub.com/content/7/1/20.short
4100  - http://mdc.sagepub.com/content/7/1/20.full
AB  - Ranolazine is an anti-ischemic agent indicated for the treatment of chronic angina. Its effects occur without clinically significant changes in heart rate or blood pressure. However, because ranolazine is associated with a mild prolongation of the QTc interval (mean change approximately 6 ms), it currently is indicated only for patients who have not responded to other therapies. Because of this potentially worrisome prolongation of the QT interval, additional safety data were sought.